Kheiron
Kheiron’s AI-powered mammography tool is designed to help radiologists detect cancer earlier. Their next-generation technology aims to increase a patient’s survival chances and pave the way for less invasive treatments.
It’s a hard fact to face, but one in six people will die of cancer. Detecting cancer and tracking it accurately is challenging and time-consuming for even the most experienced radiologists. Partly, this is due to a global shortage of radiologists, but it’s also because clinicians can’t always access the right information at the right time to make confident decisions.
Kheiron’s AI-driven mammography tool, Mia, can greatly improve the efficiency and effectiveness of early-stage cancer detection by identifying potentially cancerous tissue that radiologists could miss. Their AI-driven mammography tool aims to help detect cancer with accuracy comparable to or exceeding human radiologists. Kheiron aims to improve cancer survival chances by enabling earlier and potentially less invasive treatments. Mia has been tested with NHS clinicians and reviewed mammograms from over 10,000 women. Although most were cancer-free, it successfully identified all symptomatic cases, and flagged 11 instances that the doctors had overlooked.
Founders
Peter Kecskemethy
CEO
Peter founded two tech startups and was the lead developer in two others. He is a computer scientist, and has a PhD in High Performance Computing and Computational Statistics for Population Genetics from the University of Oxford.
Tobias Rijken
CTO
Tobias graduated from Amsterdam University College with a bachelors in Mathematics and Computer Science. He completed a masters at University College London in Computational Statistics and Machine Learning, and worked at BenevolentAI as a machine learning researcher before founding Kheiron.
Milestones
Founded at Entrepreneur First
Seed raised
Series A ($22 million) led by Atomico
Acquired by DeepHealth